Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05077514 |
Other study ID # |
00053847 |
Secondary ID |
W81XWH-13-2-032 |
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
March 1, 2012 |
Est. completion date |
January 14, 2019 |
Study information
Verified date |
October 2021 |
Source |
Medical University of South Carolina |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The study team conducted a randomized controlled clinical trial of 809 military service
members who were at increased risk for suicide but not currently in behavioral health
treatment. This study tested the effectiveness of a brief phone-based intervention (CBT-TS)
aimed at changing military member's perceptions about behavioral health therapy. Participants
completed five interviews over the course of one year to collect information about change in
behavioral health symptoms and treatment utilization.
Description:
Participants A randomized controlled trial design was used to test the efficacy of a brief,
manualized, evidence-based CBT-TS to promote treatment initiation among at-risk military
members and Veterans (W81XWH-13-2-0032; Increasing Treatment Seeking among At-Risk Service
Members Returning from Warzones, funded by the Department of Defense). Participants were
recruited through media advertisements. Ads targeted individuals who were considering help
seeking. Eligible participants: 1) served in the US Armed Forces after September 11, 2001, 2)
were not receiving behavioral health treatment at the time of the screening, and 3) endorsed
recent suicidal ideation on the PHQ-9, item 9 (i.e., score of 1 or higher on the item) or a
lifetime suicide attempt. Study procedures were reviewed and approved by the appropriate
institutional review boards.
Procedures Individuals deemed eligible after screening and who agreed to participate went
through the informed consent process and were randomly assigned to either the control or
CBT-TS condition. Participants were administered the baseline assessment with follow-up
symptom and treatment utilization assessments occurring at months 1, 3, 6, and 12. All
assessments were administered by telephone. Participants were compensated $25 for each
assessment.
Conditions:
Cognitive Behavioral Treatment for Treatment Seeking. CBT-TS is a brief, manualized,
phone-delivered, individual session lasting 45-60 minutes. CBT-TS targets a change in beliefs
that influence whether someone enters treatment. A CBT-TS session has 4 distinct, successive
stages. First, participants identify current symptoms. Second, participants describe
strategies to manage symptoms. Third, beliefs about treatment are elicited. Fourth,
participants discuss each stated belief. All participants were administered the same
structured intervention; however, content discussed was personalized. For example, while
participants may endorse similar beliefs about getting help (e.g., "Going to treatment would
mean I am weak"), their ideas surrounding that belief and the meaning of it may differ.
Therefore, while the intervention was structured, it allows for a personalized, tailored
approach.
Control condition. Participants assigned to the control condition did not receive the CBT-TS
session. They were administered assessment measures at all time points comparable to the
experimental group.
Measures Demographic variables were assessed at baseline using a structured questionnaire.
The Perceptions about Services Scale (PASS) was administered at baseline and is a 28-item
self-report measure assessing beliefs about treatment and the extent to which they intend to
initiate treatment. The PASS was originally developed to inform the development of the CBT-TS
intervention and has good test-retest reliability.
Measures of suicidal ideation, history of suicide attempt, and a range of clinical risk
factors for suicidal ideation and behavior were obtained at baseline assessment to describe
the sample, to facilitate a comparison of the CBT-TS and control group, and to guide any
statistical adjustments that may be needed in the event of differences between groups.
Suicidal ideation and suicide attempt were measured with the Columbia-Suicide Severity Rating
Scale (C-SSRS). The C-SSRS is a widely used and validated semi-structured, rater-based
interview designed to assess the severity and frequency of current and past suicidal ideation
and behaviors. The C-SSRS has strong psychometric properties, has been validated for
administration by phone, and has been used in prior research of suicidal behavior in
Veterans. Clinical risk factors for suicidal thoughts and behavior were assessed using
validated, widely used, brief, structured questionnaires including assessments of: the number
of days of alcohol use (5+ drinks) and non-prescribed drug use in the past 30 days (Addiction
Severity Index - Alcohol and Drug Scales [ASI];, pain, sleep disturbance (Insomnia Severity
Index), thwarted belonging and perceived burdensomeness (Interpersonal Needs Questionnaire),
depressive symptoms (Patient Health Questionnaire-9) and post-traumatic stress disorder
symptoms (PTSD Checklist for DSM-IV Military Version2).
Treatment utilization was assessed at months 1, 3, 6 and 12. There were two primary outcomes,
treatment initiation to address suicidality or related conditions and the number of treatment
sessions attended. Treatment initiation was assessed by asking participants if they had
attended a mental health appointment. Data were collected as to the nature of the
appointment, reason for the visit, whether they reported seeing a physician, psychologist, or
other professional, and whether the session occurred at a VA facility or outside of VA. The
other primary outcome, treatment sessions attended, was assessed by asking participants how
many mental health treatment sessions they had attended.
Logistic regression was used to assess treatment initiation, a categorical outcome. Latent
growth curve modeling was conducted to assess treatment sessions attended, a continuous
outcome.